Relates to access to appropriate drugs at reasonable prices, formulary exceptions, standing prior authorizations and external appeals; to access to retail pharmacies, prescription synchronization, limits on patient drug costs, explanations of benefits and rebates; to prescription drug synchronization; to pharmacy benefit management; and to limits on copayments and drug substitutions.
- Chamber
- House
- Introduced
- Feb 12, 2025
- Last action
- Jan 7, 2026 — REFERRED TO INSURANCE
- Session
- 2025-2026
- Momentum
- 41 · Moderate